A quick method of quantitative determination of sulbactam in human plasma, using liquid chromatography-UV spectroscopy, has been developed and validated. After derivatization with imidazole, plasma samples were treated by direct deproteinization with acetonitrile as an extraction solvent. After ultracentrifugation, sulbactam extract was directly injected onto the LC column.
Introduction
Sulbactam is given to patients in combination with β-lactam antibiotics to inhibit β-lactamase, an enzyme produced by bacteria that destroys antibiotics [1] . Sulbactam ( Fig. 1) is an irreversible inhibitor of β-lactamase; it binds to the enzyme and does not allow it to interact with the antibiotic. Due to their broad spectrum of clinical effectiveness and tolerability β-lactam antibiotics constitute one of the most important families of antimicrobial agents due [1] [2] [3] . Clinical efficacy of β-lactamase restricts the efficiency of β-lactam antibiotics and their therapeutic activity [4] [5] [6] [7] .
Sulbactam analysis has been carried out in oral and injection pharmaceutical preparations using spectrophotometric, chemiluminescence, and fluorescent methods [8] [9] [10] [11] and by capillary electrophoresis [12, 13] . Many methods of analysis of sulbactam in biological fluids and pharmaceutical formulations using high performance liquid chromatography have been developed [15] [16] [17] [18] . Moreover, the United States Pharmacopoeia (USP) recommends the use of liquid chromatographic methods in determination of sulbactam in raw materials and in its dosage forms [14] .
Sulbactam analysis has been carried out simultaneously with analysis of other β-lactamase drugs. For example, analysis of sulbactam has been performed simultaneously with analysis of: ampicillin and cefoperazone [19] , imipenem [20] , rifampicin [21] , ampicillin [22] [23] [24] , piperacillin sodium [25] , cefoperazone [26] , and others [27, 28] . The analysis involved the use of HPLC with UV or diode-array detection [20] .
In this study, we have introduced a new method to of quick determination of low concentrations of sulbactam in biological fluids by using metronidazole (Fig. 1) as an internal standard. The method has been developed by using reversed-phase high-performance liquid chromatography (HPLC) connected to TSK Gel Super ODS (50 mm × 4.6 mm i.d., 2 µm) column. For practical applications, derivatization step has been performed. This additional step has lead to lowering the detection limit and the limit of quantification based on concentration [29] . Derivatives of drugs are usually detected at different wavelengths which can increase sensitivity and allow the detection at lower concentrations.
Experimental Procedures

Materials
Potassium salt of sulbactam and metronidazole used in the experiments were received from Hikma pharmaceutics-Amman-Jordan. Imidazole, free of UV-absorbing impurities, and analytical grade of potassium dihydrogen phosphate were supplied by Merck. Chromatographic grade methanol and acetonitrile were purchased from Scharlau Chemie S.A. Pooled plasma was purchased from the Jordanian blood bank. Water used in preparation of the standards and the mobile phase was distilled and then deionized in the Department of Chemistry, Technical Tafila University.
Equipments
A spectra-physics pump SP8810 was used and injections were made with a Hamilton 25 μL syringe via rheodyne 7725 injector. The eluant was monitored using a spectra-physics variable wavelength UV-vis detector type spectra-100 at 313 nm. The column used was a TSK Gel Super ODS (50 mm × 4.6 mm i.d., 2 µm) (Stuttgart, Germany). An ODS guard column was used to protect the analytical column. A Shimadzu UV-2201 UV-vis double-beam spectrophotometer (Shimadzu, Japan) was used for scanning and selecting the detection wavelength.
Mobile phase
The mobile phase was introduced to the chromatographic system via gradient elution of solvents A (water with 5 mM tetrabutylammonium hydroxide and 5 mM potassium dihydrogen phosphate solution adjusted to pH 6.0 with 5 mM HCl solution) and solvent B (methanol). The binary gradient was used at a flow rate of 1.0 mL min -1 as follows: 0 min, 25% B; 0-1.0 min, 40% B; 1.0-2.0 min, 40% B; 2.0-3.0 min, 25% B; 3-5.5 min, 25% B. The mobile phase was vacuum filtered through a 0.22 µm membrane filter prior to being used (Lida, Kenosha, WI, USA). (in µg mL -1 and mM) respectively as quality control solutions. A blank sample (a plasma sample processed without the internal standard) and a zero sample (a matrix sample processed with the internal standard) were also added to the calibration curve points. The metronidazole (internal standard) was always added during the extraction step at concentration of 25 µg mL -1 ; 0.146 mM. Plasma aliquots were stored at −70°C until assay has been performed.
Preparation of Solutions
The imidazole reagent was prepared by dissolving 13.6 g of imidazole in 50 mL of water. 2 mL of 0.5 M HCl was added with stirring and the pH of the solution was adjusted to 6.8 using 5 M Na 2 HPO 4 . The derivatization of sulbactam was done by addition of 100 µL of imidazole reagent to the plasma samples (500 µL each). The samples were freshly prepared; they were stored at a temperature of -60 to -70°C if the assays were to be performed at a later time. 500 µL plasma of each sample was transferred into a 1.5 mL micro-centrifuge tube. 100 μL of metronidazole working solution (25 μg mL -1 ) were added and mixed by vortex for 10 seconds. Then the samples were spiked with 100 μL of imidazole solution, which was prepared as described above. Using a vortex, the samples were mixed for 10 seconds and
Derivatization and extraction procedure for sulbactam
Quick bioanalytical method of quantification and validation of sulbactam in plasma using high performance liquid chromatography left to stand for 10 minutes to allow the derivatization reaction to complete. 800 μL of acetonitrile (HPLC grade) were added to the mixture to precipitate proteins, followed by mixing for 30 seconds using the vortex. The micro-centrifuge tubes were then moved to a centrifuge and the precipitate was separated at a speed of 5000 rpm for 17 minutes. 25 μL of the supernatant was introduced to the HPLC system at room temperature.
Results and Discussion
Optimization of chromatographic conditions
Detection
Sulbactam potassium showed no significant UV maximum absorption at longer wavelength, only descending absorption with a minimum at 225 nm. In order to use UV detection at longer wavelength the plasma samples were derivatized with the imidazole reagent prior to carrying the analysis (Scheme 1). The procedure readily produced a derivative absorbing UV radiation at 313 nm (Fig. 2) . A similar study was performed by Gomis et al., including similar conditions, but without the derivatization step. This work was repeated in our laboratory, but the detection limit was relatively high (3 µg mL -1 ) and the method showed a poor resolution. Imidazole derivatization of sulbactam involves formation of a fragment arising via opening of both rings of the bicycle followed by desulfonization. Metronidazole (Fig. 1b) shows a significant absorption at 313 nm without derivatization.
All experiments were performed at room temperature and the sulbactam concentrations were determined by HPLC after derivatization with imidazole. Initially, the performance of several organic solvents at different pH was examined. The best results were recorded using acetonitrile (HPLC grade) in the extraction step, potassium dihydrogen phosphate solution adjusted to pH 6.0 as a buffer, and methanol as the mobile phase; the derivatization step provided an enhancement in sensitivity of the detector. The derivatized sulbactam showed large peak area and shifted the wavelength to 313 nm compared to underivatized sulbactam (descending curvature to 225 nm). As a result, the limit of quantification was lowered. This derivative was separated in a reverse-phase TSK Gel Super ODS (50 mm × 4.6 mm i.d., 2 µm) column without being interfered by other components present in plasma. For this column run time 5.6 min (see Figs. 3 and 4) .
Chromatographic system
With the initial conditions set up, one more important decision to be made before the injection of the first sample is the percent of the organic solvent in the mobile phase (B%). One approach is to use an isocratic mobile phase of some solvent strength (10% B -50% B). The initial separation with 40% methanol (Fig. 3a) had short run time but poor resolution of the sulbactam derivative. The methanol percentage was too high and the value of retention factor (k) was too small. This suggested the use of a less methanol containing solvent; 30%, 20% and 10%. No isocratic conditions resulted in adequate separation. Our results from these trials showed a problem in separation of the sulbactam derivative from the plasma peaks (Fig. 3) .
This inconvenience was overcome by changing isocratic to gradient elution which controls the solvent strength in the mobile phase. For the best separation, however, a maximum value of resolution R s for both sulbactam and metronidazole observed was corresponding to the gradient time described previously in the experimental part (Fig. 4) .
The nature of the column packing can have a major effect on band spacing. Here the change in column size and packing was combined with changes in the mobile phase to optimize band spacing (see above). Using short columns packed with small particles (50 mm × 4.6 mm i.d., 2 µm) operated at a flow rate of 1 mL min −1 resulted in quick and reliable analysis. As has been demonstrated [30] , the use of small particles in short columns allowed for an increase in the flow rate without loss of effectiveness, as these particles are less resistant to mass transfer. Under these conditions, the analysis was performed within a few minutes. In addition, fast HPLC increased mass sensitivity and reduced solvent consumption. The small particle size reduced the plate height and increases plate number reaching 10,000 plates in 5 cm of column length. A special advantage of high speed columns, with low ) (t R = 5.6 min) as internal standard: a) Dissolved in mobile phase (A) up; b) Extracted from plasma as described in the experimental part Quick bioanalytical method of quantification and validation of sulbactam in plasma using high performance liquid chromatography dead volumes, was rapid re-equilibration times of stationary phase by the mobile phase. The addition of ion pairing reagents improved the chromatographic resolution. During this study enough ion pair reagent was added to the mobile phase to cover the stationary phase completely, thereby minimizing retention at high pH. It was found that at low pH (< 4.0) the sulbactam derivative molecules were strongly retained in comparison to the results observed at high pH values. The maximum retention occurred at pH = 2 and the minimum retention at pH = 6.8; the pH of 6 was chosen as the optimum pH value.
Validation parameters
Linearity and limit of quantitation
A series of standard plasma solutions, previously spiked with sulbactam, were employed as calibrators for constructing calibration growth curves covering the concentration range of 0.05 -4.0 μg mL -1 . The sulbactam derivative and the internal standard were extracted using the method described in the experimental part. Linearity was demonstrated by calculating the correlation coefficients R. Each point was established from an average of seven determinations (Table 1) . A good linear relationship between the detector signal and the spiked concentrations was found, as described by the following linear equation: Y = 0.9643X + 0.007 (r 2 = 0.9996, r = 0.9998), where Y is the area ratio (area drug / area internal standard) and X is the concentration (µg mL -1 ) (Fig. 5) . Values of the correlation coefficients of determination were all satisfactory. Detection limit was determined as the concentration of components giving a signal to noise ratio 2.5:1. The limit of detection (LOD) was found to be 0.03 µg mL -1 . The limit of quantitation (LOQ) of the sulbactam derivative in plasma was chosen as the concentrations used for the lowest concentration level on the calibration curves (0.05 µg mL -1 ) for which the coefficient of variation was 5.655.
Accuracy and precision
Better precision can be obtained by increasing S/N ratio. This can be achieved by either an increase in signal or decrease in noise. Since detector noise does not vary much with wavelengths above 200 nm, the wavelength maximum corresponds to the maximum S/N [19] . Method and system precision was evaluated by analyzing plasma quality control samples spiked with sulbactam at four different concentration levels namely 0.15, 0.3, 1.5 and 3.0 μg mL -1 using six replicate determinations. Good method/system precision was demonstrated for the analysis. The analysis exhibited coefficients of variation ranging from 2.333 to 8.073% for method precision (Table 1 ) and from 1.3 to 10.1% for system precision (not shown here). Accuracy of the method was determined by comparing the means of the measured concentrations (back calculation) of the controls with their nominal concentrations.
Long term stability
Long term stability of plasma quality control samples, previously spiked with sulbactam at four different concentration levels, was determined by monitoring the peak area responses after derivatization over a period of 60 days for samples stored at -70°C. The results showed that the retention times and the peak areas of the sulbactam derivative and metronidazole remained almost unchanged and no significant degradation was observed (Table 1 ). The results showed that the plasma samples could be safely stored at -70°C without degradation of sulbactam.
Freeze and thaw stability
Sulbactam stability was determined after the results of four freeze and thaw cycles were compared to the analysis with no freeze-thaw application. Four aliquots at each of the low and high concentrations were stored at -70°C for 24 hours and then thawed unassisted at room temperature. When completely thawed, one aliquot was analyzed and the other aliquots were refrozen for another 24 hours under the same conditions. The freeze-thaw cycle was repeated three more times, and the samples were analyzed at the second, third, and fourth cycles. Finally the concentration of sulbactam was back calculated and compared to the results of the analysis performed with no freeze-thaw application. The results showed that the retention times and the peak areas of the sulbactam derivative and metronidazole remained almost unchanged. Without a significant decrease in sulbactam concentration (Table 1 ). 
Specicifity
Specificity or selectivity with respect to interferences from endogenous substances in biological fluids was established by processing fourteen blank plasma samples from independent sources. None showed interferences from plasma compounds eluting at the retention times of the sulbactam derivative or metronidazole ( Table 1) .
Conclusions
A quick and simple HPLC method of analysis of sulbactam in human plasma was developed and validated.. The step of chromatographic elution provides high resolution and requires little time to perform. The TSK Gel Super ODS column (50 mm × 4.6 mm i.d., 2 µm) packed with small particles reduces the plate height and increases plate number reaching to 10,000 plates in 5 cm of column length. In addition, the use of a simple sample preparation instead of more complex extraction procedures makes this method suitable for pharmacokinetic and bioequivalence studies of formulations of biomedical applications. The calibration curves were linear within the low concentration range, analytical recoveries from human plasma were high, the method was accurate, and required a small sample volume.
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